Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
35
Warrant Exposure
30
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 54%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.39 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 0.4 months cash remaining
📜 Warrant Exercise
model 15%
• Warrant overhang: 9.3% of shares outstanding
Market Data
Market Cap$7.38M
Shares Outstanding21.57M
Float13.43M
Cash$228.7K
Debt$294.0K
Short InterestN/A
Institutional Holdings
QoQ: ↓ 62.5% shares (2026Q1 vs prior)
18 institutional holders · 950.5K shares
#1
VANGUARD CAPITAL MANAGEMENT LLC
246.1K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
194.5K shares
#3
Ikarian Capital, LLC
138.1K shares
+ 15 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest1.88M
Days to Cover1.0
% of Float14.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2025-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual MGRX Dilution Snapshot
Mangoceuticals, Inc. (MGRX) has a DilutionScore of 67/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 2.0M.
- Recent SEC activity tracked for MGRX: xbrl on 2025-12-31; xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: